Related Experiment Video
Updated: Feb 10, 2026

Imaging of Estrogen Receptor-α in Rat Pial Arterioles using a Digital Immunofluorescent Microscope
Published on: November 29, 2011
A trisubstituted pyrazole derivative reduces DMBA-induced mammary tumor growth in rats by inhibiting estrogen
Hanumappa Ananda1, Kothanahally S Sharath Kumar2, Muddenahalli S Sudhanva1
1Adichunchanagiri Institute for Molecular Medicine, Adichunchanagiri Institute of Medical Sciences, BG Nagara, Mandya, 571448, India.
Abstract:
Aberrant expression of estrogen receptor alpha (ER-α) is observed in many pathological complications like breast cancer, endometrial cancer, and in osteoporosis. ER-α plays a vital role in the initiation and progression of breast cancer and confers chemo and radioresistance to the cancer cells by upregulating expression of anti-apoptotic proteins. The synthetic pyrazole derivative 3-(1-(4-bromophenyl)-5-phenyl-1H-pyrazol-3-yl)pyridine (compound 5d) displays significant cytotoxicity against mammary carcinoma cells. Molecular docking studies revealed that compound 5d binds to ligand binding domain of (ER-α). In vivo studies were carried out to investigate ER-α expression by immunohistochemistry and quantitative RT-PCR, which revealed reduction of ER-α in tumor cells upon treatment with compound 5d indicating its ER-α antagonistic effect. Our study ascertains compound 5d as a potent inhibitor of mammary carcinoma cells.
Insights
A novel pyrazole derivative, compound 5d, effectively inhibits mammary carcinoma cell growth. This compound acts as an estrogen receptor alpha (ER-α) antagonist, reducing ER-α expression in tumor cells.
Area of Science:
- Oncology
- Endocrinology
- Medicinal Chemistry
Background:
- Aberrant estrogen receptor alpha (ER-α) expression is linked to breast cancer, endometrial cancer, and osteoporosis.
- ER-α promotes breast cancer progression and resistance to chemotherapy and radiotherapy by increasing anti-apoptotic proteins.
Purpose of the Study:
- To evaluate the anti-cancer potential of the synthetic pyrazole derivative, compound 5d.
- To investigate the mechanism of action of compound 5d, specifically its interaction with ER-α.
Main Methods:
- In vitro cytotoxicity assays against mammary carcinoma cells.
- Molecular docking studies to predict binding of compound 5d to the ER-α ligand binding domain.
- In vivo studies using immunohistochemistry and quantitative RT-PCR to assess ER-α expression in tumor cells after treatment.
Main Results:
- Compound 5d demonstrated significant cytotoxicity against mammary carcinoma cells.
- Molecular docking indicated that compound 5d binds to the ligand binding domain of ER-α.
- In vivo studies confirmed a reduction in ER-α expression in tumor cells treated with compound 5d, suggesting an antagonistic effect.
Conclusions:
- Compound 5d is a potent inhibitor of mammary carcinoma cells.
- The study identifies compound 5d as a potential ER-α antagonist with therapeutic implications for ER-α-driven cancers.
Related Concept Videos
α-Halogenation of Carboxylic Acid Derivatives: Overview
Feedback Inhibition
Internal Receptors
The Mammary Glands
Each breast features a pigmented projection known as the nipple, through which milk emerges via closely spaced openings of ducts, referred to as lactiferous ducts. Surrounding the nipple is a circular pigmented area of skin named the areola, which appears rough due to...
Cell Specific Gene Expression
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...

